Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Safety, Tolerability, Pharmacokinetics, and Clinical Outcomes Following Single-Dose IA Administration of UBX0101, a Senolytic MDM2/p53 Interaction Inhibitor, in Patients with Knee OA Hsu, B., Visich, J., Genovese, M., Walter, K., An, M., Laberge, R., Dananberg, J. WILEY. 2019
View details for Web of Science ID 000507466905164